BIOMAT Database Logo BIOMAT Database Logo

Evaluation of leukemia specific immunity in chronic myeloid leukemia. 1977

S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Chronic myeloid leukemia and NK cell immunity.
January 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Phenotypic evaluation of chronic myeloid leukemia.
January 1981, Blood cells,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Treatment-free remission and immunity in chronic myeloid leukemia.
May 2021, International journal of hematology,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia.
January 2006, Leukemia,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Chronic myeloid leukemia-specific T-cell responses.
September 2004, Haematologica,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Leukemia associated in vitro cell mediated immunity in chronic myeloid leukemia patients in remission.
December 1979, Indian journal of experimental biology,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
December 2014, Haematologica,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Development and immunological evaluation of HLA-specific chronic myeloid leukemia polyepitope vaccine in Chinese population.
June 2014, Vaccine,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia.
June 2021, Immunological medicine,
S G Gangal, and C S Joshi, and B P Gothoskar, and M P Gollerkeri, and S H Advani
Variant-specific BCR::ABL1 quantification discrepancy in chronic myeloid leukemia.
June 2024, International journal of laboratory hematology,
Copied contents to your clipboard!